GSK Blenrep combos receive positive EMA Committee opinion in relapsed/refractory multiple myeloma Ruchika Sharma25 May 2025 1:30 PM ISTGSK plc has announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the approval of...
GSK Nucala wins USFDA OK for use in adults with COPD Ruchika Sharma23 May 2025 12:17 PM ISTLondon: GSK plc has received approval from the US Food and Drug Administration (FDA) for Nucala (mepolizumab) as an add-on maintenance treatment for...
GSK Blenrep combos win approval in Japan for multiple myeloma Ruchika Sharma20 May 2025 1:45 PM ISTGSK plc has received approval for Blenrep combinations from Japan's Ministry of Health, Labour and Welfare (MHLW) for the treatment of adults with...
GSK to acquire liver disease drug Efimosfermin for up to USD 2 billion Ruchika Sharma15 May 2025 4:10 PM ISTLondon: GSK plc and Boston Pharmaceuticals, a clinical stage biopharmaceutical company developing highly targeted therapies for patients with...
GSK, partner iTeos end development programme for lung cancer drug belrestotug Ruchika Sharma14 May 2025 2:30 PM ISTGSK plc with its development partner iTeos Therapeutics, Inc., has announced that it is ending the development programme for experimental lung cancer...
GSK Blenrep combinations approved by UK MHRA in relapsed/refractory multiple myeloma Ruchika Sharma20 April 2025 10:00 AM ISTGSK plc has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has authorised Blenrep. In the UK, Blenrep is...
GSK Arexvy recommended for adults aged 50-59 at increased risk for severe RSV disease by US Advisory Committee on Immunization Practices Ruchika Sharma20 April 2025 9:00 AM ISTGSK plc has announced that the Advisory Committee on Immunization Practices (ACIP) voted in favour of recommending the use of RSV vaccines including...
GSK in breach for misleading prescription information on Omjjara: industry body Ruchika Sharma16 April 2025 2:34 PM ISTLondon: British pharmaceutical major GlaxoSmithKline (GSK) has failed to meet the required regulatory and ethical standards in the marketing and...
GSK, Pfizer resolve patent lawsuit over RSV vaccines Ruchika Sharma8 April 2025 5:10 PM ISTPfizer and GlaxoSmithKline have agreed to end a lawsuit over alleged patent infringement involving their competing respiratory syncytial virus (RSV)...
FDA Approves Gepotidacin for Uncomplicated UTIs Dr. Kamal Kant Kohli26 March 2025 8:45 PM ISTThe FDA has approved GSK's gepotidacin (Blujepa) for treating uncomplicated urinary tract infections (uUTIs) in females aged 12 and older. The...
GSK Blujepa bags USFDA nod for treatment of uUTIs in female adults, paediatric patients 12 years of age and older Ruchika Sharma26 March 2025 11:15 AM ISTLondon: GSK plc has announced that the Company has received US Food and Drug Administration (FDA) approval for Blujepa (gepotidacin) for the...
GSK application to expand use of Nucala for COPD accepted for review by EMA Ruchika Sharma25 March 2025 1:30 PM ISTIL-5 is a key cytokine (protein) in type 2 inflammation which is an underlying driver in many diseases.
